Can low free T3 with normal reverse T3 indicate reduced T4-to-T3 conversion?

Evaluating peripheral thyroid hormone conversion is a critical consideration when standard thyroid panels do not fully align with clinical presentations or treatment responses.

Biochemical patterns and clinical indicators

• Non-classical presentation: A serum pattern of low free T3 (FT3), adequate free T4 (FT4), and normal reverse T3 (rT3) is a biochemically plausible indicator of reduced peripheral T4-to-T3 conversion.
• The role of rT3: While classic deiodination impairment (such as in non-thyroidal illness syndrome) typically features elevated rT3 due to altered deiodinase 3 (DIO3) activity, a normal rT3 can occur during early systemic stress, calorie restriction, or selective downregulation of deiodinase 1 (DIO1), which simultaneously decreases rT3 production and clearance.
• Alternative biomarkers: Rather than relying solely on rT3, clinicians can utilize more direct markers of peripheral conversion efficiency, including the circulating FT3/FT4 ratio and SPINA-GD, a model-based calculation of the sum activity of peripheral deiodinases.

Genetic and molecular mechanisms

• Deiodinase 1 function: The DIO1 gene encodes the type 1 deiodinase (D1) enzyme, which is responsible for converting T4 into active T3 and degrading rT3 in peripheral tissues.
• Impact of polymorphisms: Common genetic variants within DIO1 directly alter enzymatic activity and systemic hormone balance. Specifically, the minor allele of rs11206244 and the T allele of rs2235544 are associated with higher FT4 levels and lower FT3:FT4 ratios, reflecting reduced conversion efficiency.
• Clinical implications for therapy: These genetic differences explain why some individuals, particularly those receiving levothyroxine (LT4) monotherapy, exhibit a stepwise reduction in their FT3:FT4 ratio and may struggle to achieve optimal systemic T3 levels.

Bottom line

• While a low FT3 and normal rT3 pattern is a plausible indicator of reduced T4-to-T3 conversion, genetic variations in the DIO1 gene—such as the rs11206244 and rs2235544 polymorphisms—actively drive this reduced conversion efficiency, lowering the systemic FT3/FT4 ratio.